Tomoka Oka

2PUBLICATIONS
3CO-AUTHORS
PharmacogenomicsNeurology and neuromuscular diseases
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (2)

|Aug 13, 2026
Development of glutamatergic antipsychotics requires efficient synaptic glutamatergic transmission while preventing NMDA receptor down-regulation and overactivation of extrasynaptic transmission.

|Apr 25, 2026
Combined Inhibition of TRPM4/NMDA Receptor Complex and Extrasynaptic NMDA Receptors Is Candidate Therapeutic Target for Suppression of Epileptic Seizures and Improvement of Cognitive Impairments.

Pageof 1

Frequent Collaborators

2 joint publications

Motohiro Okada

2 joint publications

Ruri Okubo

2 joint publications

Eishi Motomura